Crimean Congo Hemorrhagic Fever Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.UMIT-1 Trial Favipiravir & Ribavirin for the Treatment of CCHF
Condition: CCHF Interventions: Drug: Favipiravir; Drug: Ribavirin Sponsor: Liverpool School of Tropical Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials
Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans
Condition: Crimean-Congo Hemorrhagic Fever Interventions: Biological: KIRIM-KONGO-VAX; Other: Placebo Sponsors: Tubitak; MonitorCRO Active, not recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2017 Category: Research Source Type: clinical trials
